2012
DOI: 10.1016/j.tox.2012.07.012
|View full text |Cite
|
Sign up to set email alerts
|

Biomarker panel of cardiac and skeletal muscle troponins, fatty acid binding protein 3 and myosin light chain 3 for the accurate diagnosis of cardiotoxicity and musculoskeletal toxicity in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
39
1

Year Published

2013
2013
2016
2016

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 55 publications
(44 citation statements)
references
References 43 publications
4
39
1
Order By: Relevance
“…In contrast, plasma AST, FABP3, Myl3 and miR-133a were drastically elevated after TMPD treatment and the extent of the change was similar in both techniques. The large signalto-noise ratios seen with these biomarkers regardless of sampling technique indicate their diagnostic accuracy in line with the previous work (Pritt et al, 2008;Tonomura et al, 2009;Tonomura et al, 2012;Laterza et al, 2009). The kinetics of these biomarkers were somewhat different; plasma CK-MM and FABP3 were drastically elevated 7 hr after the TMPD treatment, whereas plasma AST, Myl3 and miR-133 reached maximum at 24 hr after the TMPD treatment.…”
Section: Discussionsupporting
confidence: 84%
See 2 more Smart Citations
“…In contrast, plasma AST, FABP3, Myl3 and miR-133a were drastically elevated after TMPD treatment and the extent of the change was similar in both techniques. The large signalto-noise ratios seen with these biomarkers regardless of sampling technique indicate their diagnostic accuracy in line with the previous work (Pritt et al, 2008;Tonomura et al, 2009;Tonomura et al, 2012;Laterza et al, 2009). The kinetics of these biomarkers were somewhat different; plasma CK-MM and FABP3 were drastically elevated 7 hr after the TMPD treatment, whereas plasma AST, Myl3 and miR-133 reached maximum at 24 hr after the TMPD treatment.…”
Section: Discussionsupporting
confidence: 84%
“…Thus, it is critical that investigators should consider the kinetics of each biomarker response to various types of compounds depending on their mode of action when interpreting results of the studies. Overall, combinational measurement of these biomarkers could supply useful information for detecting potential toxicity and target tissues for new chemical entities in nonclinical toxicological studies as several authors pointed out (Pritt et al, 2008;Tonomura et al, 2009;Tonomura et al, 2012).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Troponins I and T, FABP3, MYL3, and CK-MB were analyzed as specific biomarkers of cardiac damage. 23 No significant changes in troponins I and T, MYL3, or CK-MB were detected following KCN challenge in adult or juvenile mice. A significant increase in FABP3 was observed in the first 0.5 to 2 hours post-KCN challenge in adult mice ( Figure 14).…”
Section: Biomarkers and Histopathology Studymentioning
confidence: 91%
“…Mice were either fed (for cardiomyocyte injury measurement by plasma cardiac troponin I (cTnI), fatty acid binding protein 3 (FABP3) and myosin light chain 3 (Myl3) [30]) or fasted for 16 h (for glucose, triglyceride and insulin measurements) and anesthetized with isoflurane for facial vein puncture. Glucose and insulin tolerance tests (GTT and ITT) were performed as previously described [31].…”
Section: Methodsmentioning
confidence: 99%